Personalised medicine has, over recent years, made the transition from ambition to reality. It moves healthcare from taking a one-size-fits-all or blunt approach to something far more responsive and tailored.
The healthcare sector is undoubtedly under the spotlight right now, as the world deals with the myriad challenges of responding to the COVID-19 pandemic. One evolving area is the question of how different patient demographics experience the illness, and why certain groups seem much more at risk than others. Might they also respond very different to contrasting treatments and interventions?